Who should not take a GLP-1 for weight loss? The Wegovy, Zepbound and Foundayo labels list two contraindications: a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and a serious hypersensitivity to the drug or its ingredients, and all three carry a boxed warning about thyroid C-cell tumors. The Wegovy label says to stop at least 2 months before a planned pregnancy. Zepbound and Foundayo can make oral contraceptives less reliable, so their labels advise a non-oral or added barrier method after starting and after each dose increase. Compounded versions have no FDA label.
| Label item | Wegovy (injection and tablets) | Zepbound | Foundayo |
|---|---|---|---|
| Contraindications | Personal or family history of MTC or MEN 2; prior serious hypersensitivity to semaglutide or excipients | Personal or family history of MTC or MEN 2; known serious hypersensitivity to tirzepatide or excipients | Personal or family history of MTC or MEN 2; known serious hypersensitivity to orforglipron or excipients |
| Boxed warning | Risk of thyroid C-cell tumors | Risk of thyroid C-cell tumors | Risk of thyroid C-cell tumors (class-based) |
| Pregnancy | Stop when pregnancy is recognized; stop at least 2 months before a planned pregnancy | Stop when pregnancy is recognized | Stop when pregnancy is recognized |
| Oral contraceptives | No label instruction | Switch to non-oral or add a barrier method for 4 weeks after starting and after each dose increase | Switch to non-oral or add a barrier method for 30 days after starting and after each dose increase |
| Missed dose | Injection: take if the next dose is more than 2 days away; tablets: skip and take the next day | Take within 4 days (96 hours), otherwise skip | Take as soon as possible; do not double up |
Other reasons to talk to your clinician first
The labels list warnings rather than outright bans for a history of pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, and planned surgery with anesthesia or deep sedation (risk of pulmonary aspiration). If you take insulin or a sulfonylurea, the hypoglycemia risk is higher and doses may need to change.
Online programs and screening
A telehealth program should ask about thyroid cancer history, MEN 2, pregnancy plans and past pancreatitis before prescribing. If the intake does not ask, treat that as a warning sign; see our scam checker. Compounded semaglutide and tirzepatide have no FDA label of their own, so prescribers rely on the brand labels for these cautions. See also side effects, side-effect rates compared across the labels and drug interactions.
FAQ
Who should not take a GLP-1 for weight loss?
The Wegovy, Zepbound and Foundayo labels list two contraindications: a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and a serious hypersensitivity to the drug or its ingredients, and all three carry a boxed warning about thyroid C-cell tumors. The Wegovy label says to stop at least 2 months before a planned pregnancy. Zepbound and Foundayo can make oral contraceptives less reliable, so their labels advise a non-oral or added barrier method after starting and after each dose increase. Compounded versions have no FDA label.
Can I take a GLP-1 if a relative had thyroid cancer?
It depends on the type. The labels contraindicate GLP-1s for people with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Other thyroid cancers are not listed as contraindications, but tell your clinician about any thyroid history.
Do GLP-1s affect birth control pills?
The Zepbound label says it may reduce the effect of oral hormonal contraceptives and advises a non-oral method or an added barrier method for 4 weeks after starting and after each dose increase; the Foundayo label says 30 days. The Wegovy label has no such instruction.
What if I am planning a pregnancy?
The Wegovy label says to stop at least 2 months before a planned pregnancy. The Zepbound and Foundayo labels say to stop when a pregnancy is recognized. Talk to your clinician before trying to conceive.
Does the boxed warning mean GLP-1s cause thyroid cancer?
The warning comes from rodent studies; the labels say it is unknown whether these drugs cause thyroid C-cell tumors, including MTC, in humans. For Foundayo the warning is based on the drug class. People with MTC or MEN 2 history should not take them.
Sources
- DailyMed — Wegovy (semaglutide) injection and tablets prescribing information, revised 06/2026 (read November 8, 2026)
- DailyMed — Zepbound (tirzepatide) prescribing information, revised 08/2026 (read November 8, 2026)
- DailyMed — Foundayo (orforglipron) prescribing information, revised 07/2026 (read November 8, 2026)